SPR Therapeutics
Aug 21, 2018
Kalydeco got approved; Opdivo for SCLC; FDA approved for pain relief; GC4419 obviates
Kalydeco, the first Cystic Fibrosis drug of Vertex, got approved for infants The Food and Drug Administration has cleared Kalydeco drug of Vertex Pharmaceuticals for infants aged 12 to under 24 months. The approved drug treats the underlying cause of cystic fibrosis in children of this age with at least one mutatio...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
